PERENNIAL ALLERGIC RHINITIS
Clinical trials for PERENNIAL ALLERGIC RHINITIS explained in plain language.
Never miss a new study
Get alerted when new PERENNIAL ALLERGIC RHINITIS trials appear
Sign up with your email to follow new studies for PERENNIAL ALLERGIC RHINITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New allergy med shows promise for kids in Year-Long study
Disease control CompletedThis study looked at the long-term safety and effectiveness of a medication called TAU-284 (Bepotastine besilate) in children aged 7 to 15 with perennial allergic rhinitis (year-round allergies). Over 12 weeks, researchers tracked side effects and changes in nasal symptoms like s…
Matched conditions: PERENNIAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated May 20, 2026 11:58 UTC
-
New allergy drug shows promise for kids with constant stuffy noses
Symptom relief CompletedThis study tested a medicine called TAU-284 in 490 children aged 7 to 15 who have year-round nasal allergies (perennial allergic rhinitis). The goal was to see if it reduces sneezing, runny nose, and congestion better than a placebo. Results showed that TAU-284 improved symptoms …
Matched conditions: PERENNIAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 26, 2026 07:08 UTC
-
New study: using allergy spray only when needed may work just as well as daily use in kids
Symptom relief CompletedThis study looked at whether children with year-round allergies can use a nasal steroid spray only when they have symptoms instead of every day. 68 children aged 6-18 took part. The goal was to see if as-needed use controls symptoms just as well, while reducing side effects and m…
Matched conditions: PERENNIAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Mahidol University • Aim: Symptom relief
Last updated May 20, 2026 12:00 UTC
-
New allergy drug shows promise for kids in major trial
Symptom relief CompletedThis study tested a medicine called TAU-284 in 473 children aged 7 to 15 who have year-round nasal allergies (perennial allergic rhinitis). The goal was to see if it works better than a placebo at reducing sneezing, runny nose, and stuffiness after two weeks. The trial also check…
Matched conditions: PERENNIAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC